Tatiana Dilla
Tatiana Dilla publishes mostly in Economics and Econometrics, Endocrinology, Diabetes and Metabolism and Rheumatology, on topics such as Health Systems, Economic Evaluations, Quality of Life, Diabetes Treatment and Management and Diabetes Management and Research.
- World rank
- #3,227,597 of 7,710,434 ranked researchers
- Rank in Spain
- #72,356 of 204,306
- Works
- 94
- Citations
- 2.1k
- Citations per work
- 21.9
What does Tatiana Dilla research?
Tatiana Dilla's work is mostly in Medicine (34%), Economics, Econometrics and Finance (22%), Health Professions (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3739.3%
- Medicine3234.2%
- Health Professions55.1%
- Everything else3234.0%
- Social Sciences2122.4%
- Life Sciences44.3%
- 1Economics and Econometrics22% of their works
- 2Endocrinology, Diabetes and Metabolism21% of their works
- 3Rheumatology8% of their works
- 4Psychiatry and Mental health6% of their works
- 5General Health Professions5% of their works
- 6Immunology4% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Rheumatoid Arthritis Research and Therapies
- Pharmaceutical Economics and Policy
- Economic and Financial Impacts of Cancer
- Psoriasis: Treatment and Pathogenesis
Which keywords describe Tatiana Dilla's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cost-effectiveness Analysis, Quality of Life, Cardiovascular Disease, Diabetes, Cardiovascular Outcomes and Type 2 Diabetes.
- TH17 Cells
- Rheumatoid Arthritis
- Generic Drugs
- Drug Development Costs
- Metabolic Syndrome
- Hypoglycemia
- Type 2 Diabetes
- Diabetes
- Quality of Life
- Insulin Therapy
- Glycemic Control
- Cost-effectiveness Analysis
- Cardiovascular Disease
- Cardiovascular Outcomes
- Continuous Glucose Monitoring
- Insulin Resistance
- Cost of Care
- Financial Toxicity
- Inflammation
- IL-17
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Glycemic Control372 topics
- Insulin Therapy372 topics
- Cost-effectiveness Analysis341 topic
- Quality of Life341 topic
- Cardiovascular Disease282 topics
- Diabetes282 topics
- Cardiovascular Outcomes191 topic
- Type 2 Diabetes191 topic
- Continuous Glucose Monitoring181 topic
- Hypoglycemia181 topic
- Insulin Resistance101 topic
- Metabolic Syndrome101 topic
- Cost of Care91 topic
- Drug Development Costs91 topic
- Financial Toxicity91 topic
- Generic Drugs91 topic
- Inflammation91 topic
- Rheumatoid Arthritis91 topic
- IL-1781 topic
- TH17 Cells81 topic
Where does Tatiana Dilla work?
Tatiana Dilla's main affiliation in the publication record is Eli Lilly (Spain), Spain.
How many publications and citations does Tatiana Dilla have?
OpenAlex counts 94 works and 2,058 citations for Tatiana Dilla, an h-index of 21, ranking #3,227,597 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tatiana Dilla. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.